Se connecter Inscription gratuite

Alkermes plc BPA

Quel est le BPA de Alkermes plc?

Le BPA de Alkermes plc est 1.73

Quelle est la définition de BPA?



Le bénéfice par action (BPA) est la partie du bénéfice d’une société affectée à chaque action en circulation d’actions ordinaires. Il est ajusté pour tenir compte de la dilution et calculé sur douze mois.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

BPA des entreprises dans Health Care secteur sur NASDAQ par rapport à Alkermes plc

Que fait Alkermes plc?

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.

Entreprises avec bpa similaire à Alkermes plc